Post-IPO Equity - Outlook Therapeutics - Nov 29, 2021 Funding Round Profile - Cointime

Bitcoin $98,475.61 +0.19%
Ethereum $3,331.76 +0.41%
BNB $636.93 +1.44%
Optimism $2.25 +10.81%
Arbitrum $0.83 +9.04%
Solana $255.25 -0.44%
Polygon $0.53 +15.91%
Cosmos $7.82 +21.28%
Avalanche $43.88 +23.71%

Bitcoin $98,475.61 +0.19%
Ethereum $3,331.76 +0.41%
BNB $636.93 +1.44%
Optimism $2.25 +10.81%
Arbitrum $0.83 +9.04%
Solana $255.25 -0.44%
Polygon $0.53 +15.91%
Cosmos $7.82 +21.28%
Avalanche $43.88 +23.71%

Outlook Therapeutics

company

Funding Round

Post-IPO Equity

Money Raised

$ 57.50M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
May 26, 2020	Post-IPO Equity	$ 27.20M	Syntone Ventures	Detail
Jul 27, 2015	Series Unknown	$ 31M	Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc.	Detail
Nov 5, 2018	Post-IPO Equity	$ 20M	Biolexis	Detail
Jan 29, 2021	Post-IPO Equity	$ 35M		Detail
Feb 16, 2021	Post-IPO Equity	$ 42.60M		Detail
Sep 29, 2015	Series Unknown	0	Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc.	Detail
Feb 24, 2020	Post-IPO Equity	$ 10.20M		Detail
May 14, 2018	Post-IPO Equity	$ 15M	GMS Tenshi Holdings	Detail
May 13, 2016	IPO	$ 35M		Detail